French pharmaceutical giant Sanofi plans to invest billions of euros to expand its manufacturing in the United States, in response to President Donald Trump’s trade policies – which include threats to impose tariffs on medicines in order to increase homegrown production.
One of the world’s largest vaccine makers and a leader in anti-inflammatory drugs, Sanofi said on Wednesday that it is planning on investing $20 billion (€17.8 billion) in the next five years to expand its capacity to manufacture drugs in the US.
